Director, Medical Monitoring

Kiniksa Pharmaceuticals; Lexington (MA); On-site; USD 286,000 - 316,000; Full time

Job summary

Kiniksa Pharmaceuticals is seeking a Director of Medical Monitoring to ensure medical oversight for assigned studies in accordance with GCP. This onsite role in Lexington, MA requires MD and extensive medical monitoring experience, with a focus on Phase 2–3 trials and collaboration across cross‑functional teams.

You will contribute to safety reviews, protocol input, and monitoring plan development, partnering with Global Medical Safety, Regulatory Affairs and Data Monitoring Committees to

Qualifications

• MD degree with clinical development experience.
• 5+ years in clinical development/medical monitoring in biotech/pharma.
• Strong ability to integrate clinical, safety and scientific data.

Responsibilities

• Provide ongoing medical monitoring oversight for assigned trials, including real‑time safety review and data interpretation.
• Serve as medical point of contact for investigators and sites on eligibility and protocol questions.
• Collaborate with Global Medical Safety to review adverse events and support safety signal detection.
• Contribute to protocol design, amendments and informed consent documents.
• Develop and maintain medical monitoring plans and safety review processes.
• Partner with Clinical Operations and CRO on trial conduct and site management.

Skills

Medical monitoring

Clinical oversight

Cross‑functional collaboration

Communication

Project management

Education

MD degree

Tools

TMF system

Job description

Kiniksa Pharmaceuticals is a commercial‑stage biopharmaceutical company developing and commercializing novel therapies for diseases with unmet need, with a focus on cardiovascular indications. With deep expertise in immunology and inflammation, Kiniksa is advancing a growing portfolio of approved and investigational medicines, anchored by its lead product, ARCALYST®, the first and only FDA‑approved therapy for recurrent pericarditis. Grounded in rigorous science and bold innovation, the company fosters a highly collaborative, patient‑first culture led by accomplished life sciences leaders. At Kiniksa, talented individuals are trusted and empowered to make a real impact—shaping the future of medicine while improving the lives of patients who need it most.

The Director, Medical Monitoring, is a key role responsible for ensuring appropriate medical oversight in conducting the study protocol including the integrity of assigned clinical studies in accordance with Good Clinical Practice (GCP). This role operates as a key contributor, ensuring high quality medical review and timely assessments supporting medical decision support and program execution

This role is based in our Lexington, MA office and requires employees to be onsite five days per week.

Responsibilities (including, but not limited to)

• Provide ongoing medical monitoring oversight for assigned clinical trials, including real‑time review of safety data, adverse events, data listings, protocol deviations, eligibility, and laboratory findings to ensure data quality
• Serve as a medical point of contact for investigators and sites on eligibility, protocol interpretation, and participant management questions, including providing medical support for routine medical inquiries from internal and external study teams and sites
• Engage with investigators, advisors, and external experts to support trial execution and clinical oversight
• In collaboration with Global Medical Safety, review and assess adverse events and serious adverse events, including causality assessment, and support safety signal detection in partnership with Pharmacovigilance
• Provide clinical input into protocol design, amendments, informed consent forms, and other study‑related documents
• Review and interpret clinical and safety data to inform potential protocol adjustments and trial‑level decisions
• Develop and maintain medical monitoring plans and safety review processes for assigned studies in collaboration with Global Medical Safety
• Partner closely with Clinical Operations and CRO on trial conduct, site management, and medical monitoring activities, including leading and supporting discussions with Data Monitoring Committees (DMC)
• Partner with Biometrics and Regulatory Affairs to ensure clinical data support statistical and regulatory requirements
• Collaborate closely with cross‑functional team, including Program Management, Medical Safety/Pharmacovigilance, Regulatory Affairs, Biometrics, Medical Affairs, and CMC teams
• Contribute to safety reports, DSURs, and responses to health authority questions
• Provide clinical input into briefing documents, responses to regulatory questions, and clinical components of submissions
• Document all medical monitoring activities and communications related to assigned studies in TMF
• Support preparation for and participate as applicable in site initiation visits and investigator meetings

Standout Skills for Impact:

• Clear and credible communication skills with investigators, cross‑functional teams, senior management
• Ability to anticipate enrollment and endpoint challenges before they arise
• Proactive approach in identifying trends early and defining mitigation strategies rather than reacting to problems
• Personable ability to build constructive relationships with investigators and study team
• Ability to handle difficult conversations around protocol deviations, eligibility decisions, and safety events diplomatically

Qualifications and Experience:

• 5+ years of clinical development and/or medical monitoring experience in biotechnology and/or pharmaceutical organizations, with an MD degree; prior experience as a practicing physician is preferred
• Hands‑on medical monitoring experience in Phase 2‑3 clinical trials
• Experience supporting programs through key clinical trial milestones (e.g., study start‑up, interim analyses, pivotal study conduct)
• Strong ability to integrate clinical, safety, and scientific data into sound clinical and risk‑benefit decisions
• Solid understanding of global clinical development, GCP, and patient safety requirements
• Familiarity with regulatory submissions (e.g., NDA, BLA, MAA) and support of health authority interactions
• Comfortable operating as an individual contributor in a lean, dynamic environment
• Models transparency, collaboration, and patient‑centric decision‑making
• Ability to travel domestically and internationally up to 20% for purposes such as site visits and investigator meetings

Compensation decisions are based on objective criteria including role responsibilities, experience/qualifications, internal equity, geographic location, and external market benchmarks.

Pay Range

$286,000 - $316,000 USD

Kiniksa is an Equal Opportunity employer and will consider you without regard to your race, color, religion, sex, sexual orientation, gender identity, transgender status, age, genetics, national origin, protected veteran status, or disability status, or any other legally protected category. We will ensure that individuals with disabilities are provided reasonable accommodation to participate in the job application or interview process, to perform essential job functions, and to receive other benefits and privileges of employment. Please contact us to request accommodation.

Kiniksa does not accept unsolicited resumes from staffing agencies or search firms. Any resumes submitted without a signed agreement will be considered property of Kiniksa, and no fees will be paid.

Voluntary Self-Identification

For government reporting purposes, we ask candidates to respond to the below self‑identification survey.Completion of the form is entirely voluntary. Whatever your decision, it will not be considered in the hiringprocess or thereafter. Any information that you do provide will be recorded and maintained in aconfidential file.

As set forth in Kiniksa Pharmaceuticals’s Equal Employment Opportunity policy,we do not discriminate on the basis of any protected group status under any applicable law.

If you believe you belong to any of the categories of protected veterans listed below, please indicate by making the appropriate selection.As a government contractor subject to the Vietnam Era Veterans Readjustment Assistance Act (VEVRAA), we request this information in order to measurethe effectiveness of the outreach and positive recruitment efforts we undertake pursuant to VEVRAA. Classification of protected categoriesis as follows:

A 'disabled veteran' is one of the following: a veteran of the U.S. military, ground, naval or air service who is entitled to compensation (or who but for the receipt of military retired pay would be entitled to compensation) under laws administered by the Secretary of Veterans Affairs; or a person who was discharged or released from active duty because of a service‑connected disability.

A 'recently separated veteran' means any veteran during the three‑year period beginning on the date of such veteran's discharge or release from active duty in the U.S. military, ground, naval, or air service.

An 'active duty wartime or campaign badge veteran' means a veteran who served on active duty in the U.S. military, ground, naval or air service during a war, or in a campaign or expedition for which a campaign badge has been authorized under the laws administered by the Department of Defense.

An 'Armed forces service medal veteran' means a veteran who, while serving on active duty in the U.S. military, ground, naval or air service, participated in a United States military operation for which an Armed Forces service medal was awarded pursuant to Executive Order 12985.

Select...

Voluntary Self-Identification of Disability

Form CC-305

Page 1 of 1

OMB Control Number 1250-0005

Expires 04/30/2026

Why are you being asked to complete this form?

We are a federal contractor or subcontractor. The law requires us to provide equal employment opportunity to qualified people with disabilities. We have a goal of having at least 7% of our workers as people with disabilities. The law says we must measure our progress towards this goal. To do this, we must ask applicants and employees if they have a disability or have ever had one. People can become disabled, so we need to ask this question at least every five years.

Completing this form is voluntary, and we hope that you will choose to do so. Your answer is confidential. No one who makes hiring decisions will see it. Your decision to complete the form and your answer will not harm you in any way. If you want to learn more about the law or this form, visit the U.S. Department of Labor’s Office of Federal Contract Compliance Programs (OFCCP) website at www.dol.gov/ofccp .

Disabilities include, but are not limited to:

• Alcohol or other substance use disorder (not currently using drugs illegally)
• Autoimmune disorder, for example, lupus, fibromyalgia, rheumatoid arthritis, HIV/AIDS
• Blind or low vision
• Cancer (past or present)
• Cardiovascular or heart disease
• Celiac disease
• Cerebral palsy
• Deaf or serious difficulty hearing
• Diabetes
• Disfigurement, for example, disfigurement caused by burns, wounds, accidents, or congenital disorders
• Epilepsy or other seizure disorder
• Gastrointestinal disorders, for example, Crohn's Disease, irritable bowel syndrome
• Intellectual or developmental disability
• Mental health conditions, for example, depression, bipolar disorder, anxiety disorder, schizophrenia, PTSD
• Missing limbs or partially missing limbs
• Mobility impairment, benefiting from the use of a wheelchair, scooter, walker, leg brace(s) and/or other supports
• Nervous system condition, for example, migraine headaches, Parkinson’s disease, multiple sclerosis (MS)
• Neurodivergence, for example, attention‑deficit/hyperactivity disorder (ADHD), autism spectrum disorder, dyslexia, dyspraxia, other learning disabilities
• Partial or complete paralysis (any cause)
• Pulmonary or respiratory conditions, for example, tuberculosis, asthma, emphysema
• Short stature (dwarfism)
• Traumatic brain injury

Disability Status Select...

PUBLIC BURDEN STATEMENT: According to the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless such collection displays a valid OMB control number. This survey should take about 5 minutes to complete.